These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
670 related items for PubMed ID: 29544690
1. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs. De Vleeschauwer AR, Zhou X, Lefebvre DJ, Garnier A, Watier F, Pignon C, Lacour SA, Zientara S, Bakkali-Kassimi L, De Clercq K, Klonjkowski B. Vaccine; 2018 Apr 12; 36(16):2193-2198. PubMed ID: 29544690 [Abstract] [Full Text] [Related]
2. Expression of the Foot-and-Mouth Disease Virus VP1 protein using a replication-competent recombinant canine adenovirus type 2 elicits a humoral antibody response in a porcine model. Liu Y, Hu R, Zhang S, Zhang F, Li Z, Wei X, Chen L. Viral Immunol; 2006 Apr 12; 19(2):202-9. PubMed ID: 16817763 [Abstract] [Full Text] [Related]
3. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X, Liu R, Tang H, Jin M, Chen H, Qian P. Vaccine; 2008 May 23; 26(22):2714-22. PubMed ID: 18436351 [Abstract] [Full Text] [Related]
4. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice. Zhou G, Wang H, Wang F, Yu L. Res Vet Sci; 2013 Jun 23; 94(3):796-802. PubMed ID: 23267820 [Abstract] [Full Text] [Related]
5. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle. Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Tamil Selvan RP, Hosamani M, Saravanan P, Basagoudanavar SH, de Los Santos T, Venkataramanan R, Rodriguez LL, Grubman MJ. Vet Microbiol; 2017 May 23; 203():196-201. PubMed ID: 28619144 [Abstract] [Full Text] [Related]
6. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs. Du Y, Dai J, Li Y, Li C, Qi J, Duan S, Jiang P. Vet Immunol Immunopathol; 2008 Aug 15; 124(3-4):274-83. PubMed ID: 18511133 [Abstract] [Full Text] [Related]
7. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle. Steigerwald R, Brake DA, Barrera J, Schutta CJ, Kalla M, Wennier ST, Volkmann A, Hurtle W, Clark BA, Zurita M, Pisano M, Kamicker BJ, Puckette MC, Rasmussen MV, Neilan JG. Vaccine; 2020 Jan 22; 38(4):769-778. PubMed ID: 31718901 [Abstract] [Full Text] [Related]
8. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice. Ren ZJ, Tian CJ, Zhu QS, Zhao MY, Xin AG, Nie WX, Ling SR, Zhu MW, Wu JY, Lan HY, Cao YC, Bi YZ. Vaccine; 2008 Mar 10; 26(11):1471-81. PubMed ID: 18289743 [Abstract] [Full Text] [Related]
9. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine. Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG. Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056 [Abstract] [Full Text] [Related]
10. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine. Fernandez-Sainz I, Medina GN, Ramirez-Medina E, Koster MJ, Grubman MJ, de Los Santos T. Virology; 2017 Feb 14; 502():123-132. PubMed ID: 28039799 [Abstract] [Full Text] [Related]
11. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles. Gullberg M, Lohse L, Bøtner A, McInerney GM, Burman A, Jackson T, Polacek C, Belsham GJ. PLoS One; 2016 Feb 14; 11(6):e0157435. PubMed ID: 27294397 [Abstract] [Full Text] [Related]
12. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers. Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, Pacheco JM, LaRocco M, Palarea-Albaladejo J, Brake D, Rieder E, Arzt J, Barlow JW, Golde WT. Vaccine; 2019 Sep 30; 37(42):6221-6231. PubMed ID: 31493951 [Abstract] [Full Text] [Related]
15. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle. Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T. Clin Vaccine Immunol; 2015 Nov 25; 23(2):125-36. PubMed ID: 26607309 [Abstract] [Full Text] [Related]
18. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus. Zheng M, Jin N, Zhang H, Jin M, Lu H, Ma M, Li C, Yin G, Wang R, Liu Q. J Virol Methods; 2006 Sep 25; 136(1-2):230-7. PubMed ID: 16780963 [Abstract] [Full Text] [Related]
19. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine. Fernandez-Sainz I, Gavitt TD, Koster M, Ramirez-Medina E, Rodriguez YY, Wu P, Silbart LK, de Los Santos T, Szczepanek SM. Vaccine; 2019 Jun 06; 37(26):3435-3442. PubMed ID: 31085001 [Abstract] [Full Text] [Related]
20. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease. Lu Z, Bao H, Cao Y, Sun P, Guo J, Li P, Bai X, Chen Y, Xie B, Li D, Liu Z, Xie Q. Vaccine; 2008 Dec 19; 26 Suppl 6():G48-53. PubMed ID: 19178894 [Abstract] [Full Text] [Related] Page: [Next] [New Search]